Finasteride
Drug Approvals
(British Approved Name, US Adopted Name, rINN)
International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Finasterid; Finasterida; Finasteridas; Finasteride; Finasteridi; Finastendum; Finasztend; MK-906; MK-0906; YM-152.
Pharmacopoeias. In Europe and US.
European Pharmacopoeia, 6th ed. (Finasteride). A white or almost white crystalline powder. It exhibits polymorphism. Practically insoluble in water freely soluble in dehydrated alcohol and in dichloromethane. Protect from light.
The United States Pharmacopeia 31, 2008 (Finasteride). A white to off-white crystalline solid. Very slightly soluble in water freely soluble in alcohol and in chloroform. Store in airtight containers.
Adverse Effects
The most commonly reported adverse effects of finasteride are decreased libido, erectile dysfunction, ejaculation disorders, and reduced volume of ejaculate. Breast tenderness and enlargement (gynaecomastia) may occur, and there have been reports of hypersensi-tivity reactions such as swelling of the lips and face, pruritus, urticaria, and rashes. Read more [...]
